Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature

Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after k...

Descripción completa

Detalles Bibliográficos
Autores principales: Ammari, Zaid, Pak, Stella C., Ruzieh, Mohammed, Dasa, Osama, Tiwari, Abhinav, Jaume, Juan C., Alfonso-Jaume, Maria A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966672/
https://www.ncbi.nlm.nih.gov/pubmed/29854487
http://dx.doi.org/10.1155/2018/4606491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966672/
https://www.ncbi.nlm.nih.gov/pubmed/29854487
http://dx.doi.org/10.1155/2018/4606491

Ejemplares similares